当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析 - 现金流量表

国药一致

(000028)

  

流通市值:105.17亿  总市值:122.44亿
流通股本:5.26亿   总股本:6.12亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金38,712,113,468.5517,195,099,250.378,140,337,898.3555,095,736,377.3
  收到的税费返还--3,681,379.093,635,067.14
  收到其他与经营活动有关的现金288,232,007.36153,266,121.8690,056,086.9541,664,883.96
  经营活动现金流入小计39,000,345,475.9117,348,365,372.178,834,075,364.3455,641,036,328.4
  购买商品、接受劳务支付的现金37,378,239,733.5918,626,877,356.7670,018,086,293.7350,834,224,228.62
  支付给职工以及为职工支付的现金1,493,805,376.15797,322,261.093,223,726,221.652,414,309,062.07
  支付的各项税费810,086,474.09421,484,768.591,739,622,028.721,257,341,788.57
  支付其他与经营活动有关的现金836,933,346.32438,014,462.062,214,051,894.971,598,237,669.55
  经营活动现金流出小计40,519,064,930.1520,283,698,848.577,195,486,439.0756,104,112,748.81
  经营活动产生的现金流量净额-1,518,719,454.24-2,935,333,476.41,638,588,925.27-463,076,420.41
二、投资活动产生的现金流量:
  收回投资收到的现金2,327,084.682,327,084.6821,418,327.563,912,324.06
  取得投资收益收到的现金34,195,604.59767,164.1999,180,621.5598,930,230.73
  处置固定资产、无形资产和其他长期资产收回的现金净额986,656.94660,709.061,815,1311,256,021.6
  收到的其他与投资活动有关的现金--61,800.83-
  投资活动现金流入小计37,509,346.213,754,957.93122,475,880.94104,098,576.39
  购建固定资产、无形资产和其他长期资产支付的现金59,415,362.0726,970,163.32217,347,683.01173,166,529.73
  投资支付的现金--480,000480,000
  取得子公司及其他营业单位支付的现金--7,415,683.187,415,683.18
  支付其他与投资活动有关的现金--157,335.53114,345.33
  投资活动现金流出小计59,415,362.0726,970,163.32225,400,701.72181,176,558.24
  投资活动产生的现金流量净额-21,906,015.86-23,215,205.39-102,924,820.78-77,077,981.85
三、筹资活动产生的现金流量:
  吸收投资收到的现金--6,900,0006,900,000
  其中:子公司吸收少数股东投资收到的现金--6,900,0006,900,000
  取得借款收到的现金1,207,659,924.94749,054,989.351,672,489,123.021,496,109,982.71
  收到其他与筹资活动有关的现金65,575,748.1718,103,821.382,391,696.5863,280,877.43
  筹资活动现金流入小计1,273,235,673.11767,158,810.651,761,780,819.61,566,290,860.14
  偿还债务支付的现金685,426,579.41152,311,155.111,531,322,545.461,186,666,726.73
  分配股利、利润或偿付利息支付的现金446,189,637.8550,600,494.35477,097,339.49381,174,391.92
  其中:子公司支付给少数股东的股利、利润19,481,501.813,313,975.4590,808,325.739,623,253.96
  支付其他与筹资活动有关的现金600,924,052.11231,852,652.731,115,587,136.011,312,302,642.93
  筹资活动现金流出小计1,732,540,269.37434,764,302.193,124,007,020.962,880,143,761.58
  筹资活动产生的现金流量净额-459,304,596.26332,394,508.46-1,362,226,201.36-1,313,852,901.44
四、汇率变动对现金及现金等价物的影响328,320.75-566.2-74,016.45-73,715.79
五、现金及现金等价物净增加额-1,999,601,745.61-2,626,154,739.53173,363,886.68-1,854,081,019.49
  加:期初现金及现金等价物余额7,297,008,417.557,297,008,417.557,123,644,530.877,123,644,530.87
  期末现金及现金等价物余额5,297,406,671.944,670,853,678.027,297,008,417.555,269,563,511.38
补充资料:
  净利润647,798,030.55-1,128,348,677.76-
  资产减值准备-46,072,997.39-290,177,026.92-
  固定资产和投资性房地产折旧82,990,425.25-1,197,864,066.99-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧82,990,425.25---
  无形资产摊销30,325,955.39-63,316,723.92-
  长期待摊费用摊销62,202,587.17-168,172,386.31-
  处置固定资产、无形资产和其他长期资产的损失-533,367.37--7,956,341.59-
  固定资产报废损失296,413.63-1,550,354.65-
  公允价值变动损失7,058,447.12--3,128,755.42-
  财务费用70,181,014.55-194,497,657.99-
  投资损失-125,131,974--291,250,467.53-
  递延所得税-20,487,159.58--80,654,991.55-
  其中:递延所得税资产减少-14,173,889.87--60,019,381.15-
    递延所得税负债增加-6,313,269.71--20,635,610.4-
  存货的减少-46,799,162.75--721,590,981.71-
  经营性应收项目的减少-1,193,847,312.01--1,484,400,432.78-
  经营性应付项目的增加-1,375,839,904.3-1,308,619,104.31-
  其他-90,298,000.45--213,622,715.06-
  不涉及现金收支的投资和筹资活动金额其他项目394,249,245.08-460,328,993.05-
  现金的期末余额5,297,406,671.94-7,297,008,417.55-
  减:现金的期初余额7,297,008,417.55-7,123,644,530.87-
  现金及现金等价物的净增加额-1,999,601,745.61-173,363,886.68-
公告日期2026-08-292026-04-302026-04-022025-10-31
审计意见(境内)标准无保留意见
TOP↑